MedCity News

virtual therapy psychiatry mental health

What Are the Biggest Mistakes Employers Make When Introducing Digital Mental Health Solutions?

Senior couple having coffee in front of suburban home

DiMe, 20+ Partners Launch New Effort to Help Older Adults Age in Place

The Digital Medicine Society launched a new initiative — it seeks to establish a roadmap for how technology can support older adults who want to age safely at home. The project will bring together health systems, home health agencies and tech companies to develop products, policy guidance and case studies for scalable home care.

By Katie Adams

BioPharma, Pharma

Neurocrine Bio Drug Licensed From Takeda Flunks Mid-Stage Test in Depression

The Phase 2 failure in major depressive disorder marks the second time in a little more than a year that Neurocrine Biosciences has reported a drug licensed from Takeda Pharmaceutical fell short in the clinic. Last year, a different drug from this partnership failed a mid-stage test in schizophrenia.

By Frank Vinluan

MedCity Influencers

Why Elderly Americans Are Bearing the Brunt of the Government Shutdown’s Impact

Time is of the essence, particularly for those with cognitive conditions. The loss of telehealth flexibilities, combined with disruptions to Medicaid, could have devastating consequences for millions of patients with dementia and other cognitive and behavioral conditions.

By Julius Bruch

Latest Video

Latest News

MedCity Influencers

Not All Military Payers Are the Same — And That Matters More Than Ever

Too often, providers handle all military claims the same way — sending them to the VA and hoping for the best. But there are multiple payer types, and they function very differently.

By Zachary Schultz

BioPharma

FDA Will Remove Warnings for HRT Products Used for Menopause

The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated.

By Marissa Plescia

Integrating GLP-1s: How Berry Street is Redefining Nutrition Care

Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.

By MedCity News

Startups, Health Tech Artificial Intelligence,

How One CEO Thinks Ambient Scribes Can Differentiate Themselves

Startups in the ambient documentation space are moving beyond simple scribing to tools that can handle tasks like intake, coding and care coordination, according to Heidi Health CEO Tom Kelly. Standing out in this crowded market is a challenge, and companies’ success will hinge on creating products clinicians actually want to use, he added.

By Katie Adams

BioPharma, Pharma

Eli Lilly Strikes Another Genetic Meds Deal, Gaining Global Rights to MeiraGTx Retinal Gene Therapy

Eli Lilly is paying $75 million up front for global rights to AAV-AIPL1, a gene therapy on track for U.S. and European regulatory submissions in the rare, inherited eye disorder Leber congenital amaurosis 4, or LCA4. The deal brings to Lilly another late-stage gene therapy for the eyes following the pharma giant’s October acquisition of Adverum Biotechnologies and its lead program for wet AMD.

By Frank Vinluan

MedCity Influencers

What Can Healthcare Today Learn From Apple Circa 2007? A Lot, Actually.

The future of healthcare isn’t about one company “owning it all.” It’s about building the kind of ecosystem Apple unlocked with the iPhone and its App Store — one that empowers and changes the game for everyone.

By Ali Diab

Transforming the OR: CEO Reveals Game-Changing AI Tech for Better Efficiency

How Apella leverages technology to increase OR efficiency.

By MedCity News

MedCity Influencers

The Doctor’s Monopoly Is Dead and We’re All Better For It

Authority built on information control cannot survive in the age of AI and instant access. But authority built on wisdom, judgment, empathy, and genuine partnership? That's eternal. And it's exactly what patients have been asking for all along.

By Neal K. Shah

Devices & Diagnostics, Health Tech Providers,

the screen of ventilator monitoring in operating room

How Philips Uses Monitoring Tech to Help Close Care Access Gaps

Philips is using its patient monitoring devices to help health systems deliver care more efficiently, especially in areas with specialist shortages. The company’s connected devices enable continuous monitoring from home to hospital and back, which can reduce diagnostic delays and improve patient safety, said Nick Wilson, Philps’ vice president of product.

By Katie Adams

Solera Health’s Playbook To Beat Rising Employer Expenses

Solera Health is working to streamline employer contracting with health tech.

By MedCity News

Health Tech

Amae Health Raises $25M to Improve Care for Severe Mental Illness

Amae Health’s Series B round was led by Altos Ventures and included participation from Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital and 8VC.

By Marissa Plescia

BioPharma, Pharma

Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera

Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer Metsera share tops the up to $86.20 Novo Nordisk was willing to pay. The financial consideration and the greater certainly of a deal close tipped the balance in Pfizer’s favor, ending a bidding war for Metsera and its next-generation obesity medications.

By Frank Vinluan

MedCity Influencers

Stronger Data Governance and Reliability Standards Needed for Wearables to Power Tech-Enabled Care

To shift wearables from wellness tools to useful drivers of disease management, the data they generate must be as trustworthy as it is plentiful. Clear frameworks that govern how information is gathered and used are needed, along with standards for the accuracy and reliability of devices

By Dr. Lucienne Marie Ide

MedCity Influencers

More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases

We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today.

By Eitan Raveh

Consumer / Employer

Carrum Health Expands SUD Treatment Program to Include Nearly All Substances

Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants.

By Marissa Plescia

BioPharma, Pharma

FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest

The six new drugs awarded FDA Commissioner’s National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to “within months.”

By Frank Vinluan

How One Company Aims to Fix the Prosthetic Fitting Process

HumoTech has developed a robotic platform that lets patients quickly try multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes.

By Katie Adams

Health Tech

MedCity FemFwd: Inside Wellcome Leap and Pivotal’s $100M Commitment To Women’s Health

In this episode, we’re joined by Dr. Renee Wittemyer, vice president of program strategy at Pivotal Ventures, and Dr. Regina Dugan, CEO of Wellcome Leap. They discuss the organizations’ recent $100 million commitment to accelerate women’s health research.

By Marissa Plescia